Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis
โ Scribed by Ferdinand I. Broekema; Frederik G. Dikkers
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 431 KB
- Volume
- 265
- Category
- Article
- ISSN
- 0302-9530
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background. Cidofovir has been reported to have activity against human papillomavirus (HPV) type 16, but no laboratory studies have been performed on HPV type 6, the main cause of recurrent respiratory papillomatosis (RRP). ## Methods. HPV6b E6 cDNAโbased C33A (nonโHPV cervical ca
## Abstract ## Objectives/Hypothesis: Recurrent respiratory papillomatosis (RRP) is a benign disease characterized by recurrent lesions in the airway. The prevalence and degree of dysplasia that is present in the natural course of RRP is not well established. Adjuvant therapies, such as cidofovir,